SCHEMBL21708768

SCHEMBL21708768

CCOCCOCCOc1cccc(O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.58
CHRNA4 P43681 1/20 0.58
KDM4E B2RXH2 4/20 0.50
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
APP P05067 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
DRD2 P14416 1/20 0.48
DRD4 P21917 1/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48
DRD3 P35462 1/20 0.48
TSHR P16473 2/20 0.46
EPHX2 P34913 1/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2211592 0.98 CHRNB2 (0.60) CHRNB2CHRNA4KDM4ELMNAMAPT
SCHEMBL16667635 0.87 KDM4E (0.59) KDM4ELMNAMAPTHTTMEN1
SCHEMBL16669059 0.87 KDM4E (0.59) KDM4ELMNAMAPTHTTMEN1
SCHEMBL15219217 0.85 KDM4E (0.57) KDM4ELMNAMAPTHTTMEN1
SCHEMBL29510932 0.85 CHRNB2 (0.69) CHRNB2CHRNA4LMNAAPPDRD2
SCHEMBL1470185 0.85 CHRNB2 (0.69) CHRNB2CHRNA4LMNAAPPDRD2
SCHEMBL23975528 0.82 CHRNB2 (0.53) CHRNB2CHRNA4APPDRD2DRD4
1-Hydroxy-3-Propoxybenzene SCHEMBL875629 0.82 CHRNB2 (0.66) CHRNB2CHRNA4APPKMT2ADRD2
1-Hydroxy-3-Propoxybenzene SCHEMBL29459552 0.82 CHRNB2 (0.66) CHRNB2CHRNA4APPKMT2ADRD2
1-Hydroxy-3-Ethoxybenzene SCHEMBL365637 0.81 CHRNB2 (0.59) CHRNB2CHRNA4KDM4EMAPTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed